Seoul, South Korea

Ahmed Asif

This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ahmed Asif. Retrieved from https://idiyas.com/inventor/ahmed-asif

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ahmed Asif: Innovator in Medicinal Chemistry

Introduction

Ahmed Asif is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target serotonin receptors. His work is crucial for advancing treatments for various central nervous system diseases.

Latest Patents

Ahmed Asif holds a patent for "Pyrazolopyrimidine derivatives having biological activity on serotonin receptor 5-HT2c." This invention relates to the medicinal use of pyrazolopyrimidine compounds, which demonstrate superior effects as serotonin 5-HT receptor ligands. These compounds are particularly useful in the prevention and treatment of central nervous system diseases, including obesity, depression, anxiety, and withdrawal symptoms associated with drug abuse.

Career Highlights

Ahmed Asif is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in medicinal chemistry. His innovative work has led to advancements in understanding and treating serotonin-related conditions.

Collaborations

Some of his notable coworkers include Ae Nim Pae and Woo-Kyu Park, who contribute to the collaborative efforts in research and development at the institute.

Conclusion

Ahmed Asif's contributions to medicinal chemistry and his innovative patent highlight his role as a key figure in the fight against central nervous system diseases. His work continues to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…